Abbott Laboratories Valuation
| ABL Stock | EUR 108.06 0.44 0.41% |
At this time, the firm appears to be fairly valued. Abbott Laboratories shows a prevailing Real Value of €107.31 per share. The current price of the firm is €108.06. Our model approximates the value of Abbott Laboratories from analyzing the firm fundamentals such as profit margin of 0.16 %, and Return On Equity of 0.19 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Abbott Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Abbott Laboratories is based on 3 months time horizon. Increasing Abbott Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Abbott stock is determined by what a typical buyer is willing to pay for full or partial control of Abbott Laboratories. Since Abbott Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Abbott Stock. However, Abbott Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 108.06 | Real 107.31 | Hype 108.06 | Naive 107.75 |
The real value of Abbott Stock, also known as its intrinsic value, is the underlying worth of Abbott Laboratories Company, which is reflected in its stock price. It is based on Abbott Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Abbott Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Abbott Laboratories helps investors to forecast how Abbott stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abbott Laboratories more accurately as focusing exclusively on Abbott Laboratories' fundamentals will not take into account other important factors: Abbott Laboratories Total Value Analysis
Abbott Laboratories is presently estimated to have takeover price of 190.22 B with market capitalization of 167.05 B, debt of 14.52 B, and cash on hands of 8.37 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Abbott Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
190.22 B | 167.05 B | 14.52 B | 8.37 B |
Abbott Laboratories Investor Information
About 76.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 13th of April 2023. Abbott Laboratories had 2:1 split on the 1st of June 1998. Based on the key indicators related to Abbott Laboratories' liquidity, profitability, solvency, and operating efficiency, Abbott Laboratories is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Abbott Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Abbott Laboratories has an asset utilization ratio of 58.64 percent. This implies that the Company is making €0.59 for each dollar of assets. An increasing asset utilization means that Abbott Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Abbott Laboratories Ownership Allocation
Abbott Laboratories holds a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Abbott Laboratories Profitability Analysis
The company reported the revenue of 43.65 B. Net Income was 6.93 B with profit before overhead, payroll, taxes, and interest of 24.58 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Abbott Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Abbott Laboratories and how it compares across the competition.
About Abbott Laboratories Valuation
The stock valuation mechanism determines Abbott Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Abbott Laboratories. We calculate exposure to Abbott Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abbott Laboratories's related companies.Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT LABS operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 109000 people.
8 Steps to conduct Abbott Laboratories' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Abbott Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Abbott Laboratories' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Abbott Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Abbott Laboratories' revenue streams: Identify Abbott Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Abbott Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Abbott Laboratories' growth potential: Evaluate Abbott Laboratories' management, business model, and growth potential.
- Determine Abbott Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Abbott Laboratories' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |